ROIVANT SCIENCES LTD. (ROIV)

Director Gline Matthew 🟡 adjusted position in 358.5K shares (1 derivative) of Roivant Sciences Ltd. (ROIV) at $27.70 ($9.9M) Transaction Date: Mar 30, 2026 | Filing ID: 000034

MEDICUS PHARMA LTD. (MDCXW)

Director Rodgers Cathy McMorris 🟢 acquired 25.0K shares (1 derivative) of Medicus Pharma Ltd. (MDCX) at $0.50 Transaction Date: Mar 30, 2026 | Filing ID: 001032